ILLUMINA INC
StreetZero Signal 53
About ILLUMINA INC
Illumina, Inc. is a global leader in DNA sequencing and array-based technologies for genetic analysis. Founded in 1998, the public company is headquartered in San Diego, CA and operates in the biotechnology research sector. Its website is www.illumina.com and LinkedIn page lists 635,308 followers.
LATEST FUNDINGRule 144
$59K
Announced 2026-11-10
IN THE NEWS
EMPLOYEESโ
FOUNDED1998
HQSan Diego, CA, United States
Industry
Public Equity (NASDAQ)
Tags
BiotechnologyGenomicsPublic CompanyDNA Sequencing
Investors
Not disclosed in the source filing. Form D filings do not list investors โ StreetZero surfaces them from news where available.
Key highlights
- Illumina, Inc. leads in DNA sequencing and array technologies for genetic variation analysis.
- Completed a $58,948.26 Rule 144 placement in San Diego with no disclosed investors.
- Participated in a ยฃ30M genomics venture fund in 2022 to back accelerator graduates.
- Public company founded in 1998 with historical backing from ARCH Venture Partners and Venrock.
Ask StreetZero about ILLUMINA INC
Put our AI to work on this deal.
Similar companies
Other Public Equity (NASDAQ) deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account